Showing 41 - 60 results of 68 for search '"Medicaid"', query time: 0.07s Refine Results
  1. 41

    Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study by Nirmish Shah, Menaka Bhor, Lin Xie, Jincy Paulose, Huseyin Yuce

    Published 2020-06-01
    “…**Methods:** Using the Medicaid Analytic Extracts database, the first SCD-related diagnosis claim (index claim) between June 1, 2009–December 31, 2012 was identified among eligible adults. …”
    Get full text
    Article
  2. 42

    Sociodemographic and behavioral factors associated with diet quality among low-income community health center patients with hypertension. by Jessica Cheng, Katherine C Faulkner, Ashlie Malone, Kristine D Gu, Anne N Thorndike

    Published 2025-01-01
    “…<h4>Results</h4>Participants (N = 291) were mostly female (65.0%), on Medicaid (82.8%), food insecure (59.5%), and Hispanic (52.2%). …”
    Get full text
    Article
  3. 43

    Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks versus Epoetin Alfa Every Week for Cancer Patients with Anemia due to the Effect of Concomitant Myelosuppressive Chemothera... by November McGarvey, Hairong Xu

    Published 2015-11-01
    “…The 2014 Centers for Medicare and Medicaid Services (CMS) reimbursement rates used were: average sales price +12% of $3.68/mcg (DA) and $11.38/1000 IU (EA), and office-based injection cost of $25.08. …”
    Get full text
    Article
  4. 44

    Race/Ethnicity, Primary Language, and Income Are Not Demographic Drivers of Mortality in Breast Cancer Patients at a Diverse Safety Net Academic Medical Center by Divya A. Parikh, Rani Chudasama, Ankit Agarwal, Alexandar Rand, Muhammad M. Qureshi, Taylor Ngo, Ariel E. Hirsch

    Published 2015-01-01
    “…Unlike other large-scale studies, non-White race, non-English primary language, low income, or Medicaid insurance did not result in worse outcomes.…”
    Get full text
    Article
  5. 45

    Dissemination of Evidence-Based Recommendations for Sickle Cell Disease to Primary Care and Emergency Department Providers in North Carolina: A Cost Benefit Analysis by Paula Tanabe, Audrey L. Blewer, Emily Bonnabeau, Hayden B. Bosworth, Denise H. Clayton, Nancy Crego, Marian F. Earls, Kern Eason, Grayson Forlines, Gary Rains, Matthew Young, Nirmish Shah

    Published 2021-04-01
    “…Tools were made available in paper, online, and in app formats to participating managed care network practices (n=1&#8239;800). Medicaid claims data were analyzed for total costs and benefits of the toolbox dissemination for a 24-month pre- and 18-month post-intervention period. …”
    Get full text
    Article
  6. 46

    Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study by Hyeun Ah Kang, Jamie C. Barner, Kristin M. Richards, Menaka Bhor, Jincy Paulose, Abdullah Kutlar

    Published 2020-06-01
    “…**Methods:** This was a retrospective cohort study using Texas Medicaid medical and prescription claims between September 2011 and August 2016. …”
    Get full text
    Article
  7. 47

    Understanding hospital length of stay in trauma laparotomy patients: a National Trauma Database Study by Jeremy Grushka, Kosar Khwaja, Hayaki Uchino, Evan G Wong

    Published 2025-02-01
    “…Most comorbidities were associated with a long HLOS, and patients with Medicaid or Medicare had a higher likelihood of a long HLOS.Conclusion Despite the relatively homogenous trauma population, HLOS distribution varied significantly. …”
    Get full text
    Article
  8. 48

    Association of a Liver Allocation Policy Change With Domestic Travel for Liver Transplantation by Katie Ross-Driscoll, PhD, MPH, Chandrashekhar Kubal, MD, PhD, Arrey-Takor Ayuk-Arrey, MPH, Jonathan Fridell, MD, David Axelrod, MD, MBA

    Published 2025-02-01
    “…Black race, lower educational attainment, increased neighborhood social deprivation, and Medicaid were significantly associated with decreased odds of traveling beyond a neighboring region. …”
    Get full text
    Article
  9. 49

    A Contemporary Analysis of Discharge Disposition Following Total Joint Arthroplasty by Swaroopa Vaidya, MS, Gregory Panza, PhD, Jake Laverdiere, BS, Dianne Vye, MSN, RN, ONC, Jenna Bernstein, MD

    Published 2025-02-01
    “…Background: Total joint arthroplasty (TJA) represents the single largest procedural cost for the Centers for Medicare &amp; Medicaid Services. Discharge to a skilled nursing facility (SNF) remains a primary driver of post-acute care costs. …”
    Get full text
    Article
  10. 50

    Mixed-methods study to examine the response of opioid addiction treatment programmes to COVID-19: a study protocol by Sugy Choi, Rhea Naik, Kamila Kiszko, Charles Neighbors, Thomas D’Aunno

    Published 2022-07-01
    “…For the quantitative aim, we will use the Client Data System and Medicaid claims data to examine the variation in clinical practices (ie, changes in telehealth, pharmacotherapy, group vs individual counselling and urine drug screening) and retention in treatment for OUD patients across 580 outpatient clinics in NYS during the pandemic. …”
    Get full text
    Article
  11. 51

    The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation by Alexandros Briasoulis, Emmanuel Akintoye, Chakradhari Inampudi, Aziz Hammoud, Paulino Alvarez

    Published 2020-06-01
    “…Patients were grouped based on the type of insurance private/self‐pay (PV), Medicare (MC), and Medicaid (MA) at the time of listing. We conducted multivariable competing risks regression analysis on listing status and mortality on the waiting list, stratified by insurance type at the time of listing. …”
    Get full text
    Article
  12. 52

    Prevalence and Risk Factors for Opioid-Induced Constipation in an Older National Veteran Cohort by Fern FitzHenry, Svetlana K. Eden, Jason Denton, Hui Cao, Aize Cao, Ruth Reeves, Guanhua Chen, Glenn Gobbel, Nancy Wells, Michael E. Matheny

    Published 2020-01-01
    “…This research describes the prevalence and covariates associated with opioid-induced constipation (OIC) in an observational cohort study utilizing a national veteran cohort and integrated data from the Center for Medicare and Medicaid Services (CMS). Methods. A cohort of 152,904 veterans with encounters between 1 January 2008 and 30 November 2010, an exposure to opioids of 30 days or more, and no exposure in the prior year was developed to establish existing conditions and medications at the start of the opioid exposure and determining outcomes through the end of exposure. …”
    Get full text
    Article
  13. 53

    Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Franklin D. Gaylis, Bruno Emond, Ameur M. Manceur, Anabelle Tardif-Samson, Laura Morrison, Dominic Pilon, Patrick Lefebvre, Lorie A. Ellis, Hiremagalur Balaji, Andrea Ireland

    Published 2024-10-01
    “…**Methods:** Adults with high-risk NMIBC treated with BCG were selected from de-identified MarketScan® Commercial, Medicare, and Medicaid Databases (1/1/2010-2/28/2021). Adequacy of BCG induction and maintenance was evaluated from the first BCG claim until the end of the patient’s observation, using a previously published claims-based algorithm (induction: ≥5 instillations within 70 days; induction and maintenance: ≥7 instillations within 274 days of first instillation) and a definition based on the landmark Southwest Oncology Group (SWOG) trial (induction: ≥5 instillations without gaps >7 days; followed by ≥2 instillations at month 3, 6, and every 6 months thereafter). …”
    Get full text
    Article
  14. 54

    ClimaWATCH: A new interactive tool for community heat-health vulnerability assessments by Aparna Keshaviah, Dheeya Rizmie, Huihua Lu, Mike Rudacille, Eric Morris, Colleen Psomas, Farid Qamar, Xindi C. Hu

    Published 2025-01-01
    “…Nationally in 2020, excess Medicaid spending amounted to $18 million on heat stress, $15 million on electrolyte imbalance, $25 million on acute myocardial infarction, and $133 million on acute renal failure. …”
    Get full text
    Article
  15. 55

    Differences in influenza testing and treatment in micropolitan versus metropolitan areas in the U.S. using medicare claims data from 2010 to 2016 by Alexia Couture, F. Scott Dahlgren, Hector S. Izurieta, Richard A. Forshee, Yun Lu, Carrie Reed

    Published 2025-01-01
    “…Methods Using billing data from the Centers for Medicare and Medicaid Services for those aged 65 years and older, we estimated weekly rates of ordered rapid influenza diagnostic tests (RIDT) and antivirals (AV) among Medicare enrollees by core-based statistical areas (CBSAs) during 2010–2016. …”
    Get full text
    Article
  16. 56

    Validation of Mortality Data Sources Compared to the National Death Index in the Healthcare Integrated Research Database by Jamal-Allial A, Sponholtz T, Vojjala SK, Paullin M, Papazian A, Eshete B, Mahmoudpour SH, Verpillat P, Beachler DC

    Published 2025-02-01
    “…Mortality data sources, inpatient discharge, disenrollment, death master file (DMF), Center for Medicare and Medicaid Services (CMS), Utilization management data (U.M.), and online obituary data were compared to NDI.Results: Among 40,692 patients, 25,761 (63.3%) had a death date using NDI; the composite algorithm had a sensitivity of 88.9% (95% CI = 88.5%, 89.3%), specificity was 89.1% (95% CI = 88.6%, 89.6%). …”
    Get full text
    Article
  17. 57

    Racial disparities in acute care utilization among individuals with myasthenia gravis by Cynthia Qi, Pushpa Narayanaswami, Ashley E. L. Anderson, Deborah Gelinas, Yuebing Li, Jeffrey T. Guptill, Dakshinamoorthy Amirthaganesan, Charlotte Ward, Rupesh Panchal, Amit Goyal, Glenn Phillips

    Published 2025-02-01
    “…Among other covariates, Medicaid usage, exacerbation at index, and number of outpatient visits were significantly associated with acute care utilization.ConclusionRacial disparities significantly impacted acute care utilization in the first 2 years post-MG diagnosis. …”
    Get full text
    Article
  18. 58

    Hispanic Patients Undergoing Spinal Fusion for Neuromuscular Scoliosis Sustain Health Inequalities by Armando S. Martinez, David Momtaz, Travis Kotzur, Alexandra McLennan, Abdullah Ghali, Farhan Ahmad, Ebubechi Adindu, Alan C. Santiago-Rodriquez, Ali Seifi, Brian Smith

    Published 2025-01-01
    “…Additionally, Hispanic patients were more likely to be Medicaid users (67.2% vs. 46.0%, p<0.001). Hispanic patients undergoing spinal fusion with instrumentation had longer lengths of stay (LOS) (10.0 vs. 7.6 days, p<0.001), longer periods from admission to surgery (wait time) (1.6 vs. 1.0 days, p=0.046), and longer recovery times (8.5 vs. 6.7 days, p<0.001). …”
    Get full text
    Article
  19. 59

    Profiles and predictors of access to human and veterinary healthcare in multispecies households by Jennifer W. Applebaum, Courtney Dunn, Shelby E. McDonald, Kaylinn Escobar, Erin K. King, Rosalie Corona, Megan K. Mueller

    Published 2025-06-01
    “…The fifth subgroup, “Poor access” (18%), with the poorest healthcare access and highest probability of Medicaid or no insurance, highlighted significant inequalities in healthcare and veterinary care access. …”
    Get full text
    Article
  20. 60

    Cost Savings in Chronic Pain Patients Initiating Peripheral Nerve Stimulation (PNS) with a 60-Day PNS Treatment by David M. Dickerson, Hemant Kalia, Kevin E. Vorenkamp, Konstantin V. Slavin, Jonathan M. Hagedorn, Candace Gunnarsson, Eric L. Keuffel, Andrew J. Epstein, Mark Stultz, Nathan D. Crosby

    Published 2024-11-01
    “…Methods Centers for Medicare & Medicaid Services (CMS) fee-for-service (FFS) data were analyzed to identify patients with at least 12 months of follow-up (median 26.4 months) who initiated PNS treatment with: (1) 60-Day PNS or (2) PNS-BT. …”
    Get full text
    Article